Home/Filings/4/0000902664-25-004411
4//SEC Filing

Schneeberger Daniel 4

Accession 0000902664-25-004411

CIK 0001664710other

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 1:24 PM ET

Size

14.9 KB

Accession

0000902664-25-004411

Insider Transaction Report

Form 4
Period: 2025-10-15
Transactions
  • Sale

    Common Stock

    2025-10-15$17.75/sh254,669$4,520,3750 total(indirect: By ADAR1 SPVI, LP)
  • Sale

    Common Stock

    2025-10-15$17.75/sh4,391,237$77,944,4570 total(indirect: By ADAR1 Partners, LP)
  • Sale

    Common Stock

    2025-10-15$17.75/sh743,358$13,194,6050 total(indirect: By LLC)
Transactions
  • Sale

    Common Stock

    2025-10-15$17.75/sh254,669$4,520,3750 total(indirect: By ADAR1 SPVI, LP)
  • Sale

    Common Stock

    2025-10-15$17.75/sh4,391,237$77,944,4570 total(indirect: By ADAR1 Partners, LP)
  • Sale

    Common Stock

    2025-10-15$17.75/sh743,358$13,194,6050 total(indirect: By LLC)
Transactions
  • Sale

    Common Stock

    2025-10-15$17.75/sh743,358$13,194,6050 total(indirect: By LLC)
  • Sale

    Common Stock

    2025-10-15$17.75/sh4,391,237$77,944,4570 total(indirect: By ADAR1 Partners, LP)
  • Sale

    Common Stock

    2025-10-15$17.75/sh254,669$4,520,3750 total(indirect: By ADAR1 SPVI, LP)
Transactions
  • Sale

    Common Stock

    2025-10-15$17.75/sh254,669$4,520,3750 total(indirect: By ADAR1 SPVI, LP)
  • Sale

    Common Stock

    2025-10-15$17.75/sh743,358$13,194,6050 total(indirect: By LLC)
  • Sale

    Common Stock

    2025-10-15$17.75/sh4,391,237$77,944,4570 total(indirect: By ADAR1 Partners, LP)
Footnotes (2)
  • [F1]The securities to which this filing relates are held directly by ADAR1 Partners, LP, ADAR1 SPV I, LP and Spearhead Insurance Solutions IDF, LLC. As the investment manager of ADAR1 Partners, LP and ADAR1 SPV I, LP and as the sub-advisor of Spearhead Insurance Solutions IDF, LLC, ADAR1 Capital Management, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP, ADAR1 SPV I, LP and Spearhead Insurance Solutions IDF, LLC. As the general partner of ADAR1 Partners, LP and ADAR1 SPV I, LP, ADAR1 Capital Management GP, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP and ADAR1 SPV I, LP. As the manager of ADAR1 Capital Management, LLC and ADAR1 Capital Management GP, LLC, Daniel Schneeberger may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP, Spearhead Insurance Solutions IDF, LLC, and ADAR1 SPV I, LP.
  • [F2]For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Documents

1 file

Issuer

Keros Therapeutics, Inc.

CIK 0001664710

Entity typeother

Related Parties

1
  • filerCIK 0001861120

Filing Metadata

Form type
4
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 1:24 PM ET
Size
14.9 KB